11 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $2.1B | $71M | 14.4% | 19.8% | — | — | $115M |
| 2024 | $1.9B | -$36M | 12.2% | 19.3% | — | — | $77M |
| 2023 | $1.7B | -$77M | 10.0% | 18.4% | — | — | $43M |
| 2022 | $1.4B | -$73M | 9.3% | 21.4% | — | — | $65M |
| 2021 | $1.1B | -$53M | 8.3% | 19.0% | — | — | $82M |
| 2020 | $1.1B | $2M | 7.0% | 20.4% | — | — | $113M |
| 2019 | $1.1B | -$5M | 11.9% | 20.1% | — | — | $53M |
| 2018 | $37M | -$8M | 18.5% | 0.0% | — | — | $35M |
| 2017 | $6M | $541000 | 24.4% | 0.0% | — | — | $7M |
| 2016 | $0 | -$5M | — | — | — | — | $2M |
| 2015 | — | $0 | — | — | — | — | $202000 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $610M | $24M | 16.0% | 20.6% | — | — | $119M |
| Dec '25 | $564M | $11M | 14.8% | 19.8% | — | — | $115M |
| Sep '25 | $532M | $56M | 14.6% | 19.9% | — | — | $147M |
| Jun '25 | $501M | $10M | 15.0% | 20.6% | — | — | $133M |
| Mar '25 | $497M | -$7M | 13.0% | 19.0% | — | — | $86M |
| Dec '24 | $497M | -$32M | 13.3% | 20.0% | — | — | $77M |
| Sep '24 | $477M | -$4M | 12.5% | 19.6% | — | — | $68M |
| Jun '24 | $458M | $2M | 12.1% | 19.4% | — | — | $52M |
| Mar '24 | $452M | -$4M | 10.7% | 18.2% | — | — | $77M |
| Dec '23 | $433M | -$27M | 11.1% | 19.5% | — | — | $43M |
| Sep '23 | $416M | -$6M | 10.0% | 18.0% | — | — | $35M |
| Jun '23 | $411M | -$12M | 9.3% | 19.6% | — | — | $48M |
| Mar '23 | $409M | -$26M | 9.4% | 16.4% | — | — | $41M |
| Dec '22 | $399M | -$48M | 9.5% | 19.3% | — | — | $65M |
| Sep '22 | $368M | -$14M | 8.4% | 20.0% | — | — | $79M |
| Jun '22 | $326M | -$17M | 9.2% | 23.8% | — | — | $59M |
| Mar '22 | $319M | -$3M | 10.0% | 23.1% | — | — | $75M |
| Dec '21 | $308M | -$23M | 9.7% | 23.8% | — | — | $82M |
| Sep '21 | $287M | -$5M | 10.5% | 18.3% | — | — | $110M |
| Jun '21 | $276M | -$8M | 9.4% | 17.9% | — | — | $77M |
How the market has priced AHR against its own fundamentals since 2024-02 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, American Healthcare Reit, Inc.'s revenue has grown 14.4% per year, and net income grown 100.9% per year. These are computed facts, not advice.
As of FY2025, American Healthcare Reit, Inc. reported — of total debt against $115M of cash; operating income covered interest expense 4.8×.
In FY2025, gross margin was 14.4%, operating margin 19.8%, and net margin 3.4%.
As of Jun '26, American Healthcare Reit, Inc. traded at a price-to-earnings ratio of about 142.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.